Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:administeredBy |
oral
|
| gptkbp:CASNumber |
1957306-69-1
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:developedBy |
gptkb:Revolution_Medicines
|
| https://www.w3.org/2000/01/rdf-schema#label |
RMC-4630
|
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
SHP2 inhibitor
|
| gptkbp:studiedBy |
solid tumors
KRAS-mutant cancers |
| gptkbp:studiedInCombinationWith |
gptkb:cobimetinib
gptkb:AMG_510 |
| gptkbp:target |
SHP2 protein
|
| gptkbp:bfsParent |
gptkb:Revolution_Medicines
|
| gptkbp:bfsLayer |
6
|